4.7 Article

A Phase-Variable Surface Layer from the Gut Symbiont Bacteroides thetaiotaomicron

期刊

MBIO
卷 6, 期 5, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.01339-15

关键词

-

资金

  1. Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award
  2. Medical Research Program grant from the W.M. Keck Foundation
  3. David and Lucile Packard Foundation
  4. NIH [OD007290, GM081879, AI068730, AI30040]

向作者/读者索取更多资源

The capsule from Bacteroides, a common gut symbiont, has long been a model system for studying the molecular mechanisms of host-symbiont interactions. The Bacteroides capsule is thought to consist of an array of phase-variable polysaccharides that give rise to subpopulations with distinct cell surface structures. Here, we report the serendipitous discovery of a previously unknown surface structure in Bacteroides thetaiotaomicron: a surface layer composed of a protein of unknown function, BT1927. BT1927, which is expressed in a phase-variable manner by similar to 1:1,000 cells in a wild-type culture, forms a hexagonally tessellated surface layer. The BT1927-expressing subpopulation is profoundly resistant to complement-mediated killing, due in part to the BT1927-mediated blockade of C3b deposition. Our results show that the Bacteroides surface structure is capable of a far greater degree of structural variation than previously known, and they suggest that structural variation within a Bacteroides species is important for productive gut colonization. IMPORTANCE Many bacterial species elaborate a capsule, a structure that resides outside the cell wall and mediates microbemicrobe and microbe-host interactions. Species of Bacteroides, the most abundant genus in the human gut, produce a capsule that consists of an array of polysaccharides, some of which are known to mediate interactions with the host immune system. Here, we report the discovery of a previously unknown surface structure in Bacteroides thetaiotaomicron. We show that this protein-based structure is expressed by a subset of cells in a population and protects Bacteroides from killing by complement, a component of the innate immune system. This novel surface layer protein is conserved across many species of the genus Bacteroides, suggesting an important role in colonization and host immune modulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Applied

Bacteroides thetaiotaomicron rough-type lipopolysaccharide: The chemical structure and the immunological activity

Molly Dorothy Pither, Anna Illiano, Chiara Pagliuca, Amy Jacobson, Giuseppe Mantova, Alessia Stornaiuolo, Roberta Colicchio, Mariateresa Vitiello, Gabriella Pinto, Alba Silipo, Michael A. Fischbach, Paola Salvatore, Angela Amoresano, Antonio Molinaro, Flaviana Di Lorenzo

Summary: Bacteroides thetaiotaomicron, a symbiont of the human gut, is extensively studied, but little is known about its cell envelope's interaction with the immune system. This research investigates the structure and immunostimulatory properties of its lipopolysaccharide (LPS). The study reveals that the rough-type LPS produced by B. thetaiotaomicron promotes TLR2-mediated immune response but has a weak ability to engage the MD-2/TLR4 pathway.

CARBOHYDRATE POLYMERS (2022)

Article Microbiology

Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease

Yijun Zhu, Mohammed Dwidar, Ina Nemet, Jennifer A. Buffa, Naseer Sangwan, Xinmin S. Li, James T. Anderson, Kymberleigh A. Romano, Xiaoming Fu, Masanori Funabashi, Zeneng Wang, Pooja Keranahalli, Shawna Battle, Aaron N. Tittle, Adeline M. Hajjar, Valentin Gogonea, Michael A. Fischbach, Joseph A. DiDonato, Stanley L. Hazen

Summary: Recent studies have shown the critical role of gut microbiota in metabolizing dietary phenylalanine into phenylacetic acid (PAA), which is important for the production of phenylacetylglutamine (PAGln) linked to atherosclerotic cardio-vascular disease (ASCVD). Researchers have identified two different microbial pathways, involving phenylpyruvate:ferre-doxin oxidoreductase (PPFOR) and phenylpyruvate decarboxylase (PPDC), for PAA formation in the gut. The abundance of these pathways is significantly higher in ASCVD patients compared to controls. These findings provide insights into the therapeutic targeting of PAGln formation in vivo.

CELL HOST & MICROBE (2023)

Editorial Material Urology & Nephrology

A Limited Effect of Chronic Renal Insufficiency on the Colon Microbiome

Leah Guthrie, Justin. L. L. Sonnenburg, Michael. A. A. Fischbach, Timothy. W. W. Meyer

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Virology

Retroviral Infection and Commensal Bacteria Dependently Alter the Metabolomic Profile in a Sterile Organ

Jessica Spring, Vera Beilinson, Brian C. DeFelice, Juan M. Sanchez, Michael Fischbach, Alexander Chervonsky, Tatyana Golovkina

Summary: Both viruses and bacteria can produce molecular patterns that affect microbial pathogenesis and anti-microbial responses. In addition, bacteria produce metabolites, while viruses can change the metabolic profiles of infected cells. Using an unbiased metabolomics approach, this study found that viral infection significantly alters the metabolite profile of mice monocolonized with Lactobacillus murinus. These findings suggest that the changes in metabolites could play a role in viral pathogenesis or the host response against the virus, providing a new avenue for future investigations.

VIRUSES-BASEL (2023)

Article Multidisciplinary Sciences

Host-microbe co-metabolism via MCAD generates circulating metabolites including hippuric acid

Kali M. Pruss, Haoqing Chen, Yuanyuan Liu, William Van Treuren, Steven K. Higginbottom, John B. Jarman, Curt R. Fischer, Justin Mak, Beverly Wong, Tina M. Cowan, Michael A. Fischbach, Justin L. Sonnenburg, Dylan Dodd

Summary: The human gut microbiota produces various small molecules that have significant effects on host physiology. However, little is known about the origin and fate of these metabolites. In this study, researchers identified a co-metabolic pathway between the host and gut bacteria for the production of hippuric acid, a major organic acid in mammalian urine. They found that gut bacteria convert phenylalanine to phenylpropionic acid, which is then re-oxidized by the host using medium-chain acyl-CoA dehydrogenase (MCAD). Through experiments with germ-free mice, the researchers also identified other microbial metabolites processed by MCAD in the host circulation. This study reveals a novel mechanism by which mammals metabolize microbiota-derived metabolites and highlights the importance of host-microbe co-metabolism in the generation and processing of these metabolites.

NATURE COMMUNICATIONS (2023)

Review Hematology

Complement-targeted therapeutics: An emerging field enabled by academic drug discovery

Christina Lamers, Daniel Ricklin, John D. Lambris

Summary: The number of complement inhibitors approved for therapeutic use or in late-stage clinical trials has expanded rapidly in recent years. The sudden emergence of this area in biotech start-ups and pharmaceutical companies is surprising considering the well-established involvement of the complement system in various clinical conditions. However, the complement system has unique characteristics that have delayed its recognition as a traditional drug target, such as concerns about safety and the complexity of its involvement in biological processes.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome

Min Wang, Lucas J. Osborn, Sunit Jain, Xiandong Meng, Allison Weakley, Jia Yan, William J. Massey, Venkateshwari Varadharajan, Anthony Horak, Rakhee Banerjee, Daniela S. Allende, E. Ricky Chan, Adeline M. Hajjar, Zeneng Wang, Alejandra Dimas, Aishan Zhao, Kazuki Nagashima, Alice G. Cheng, Steven Higginbottom, Stanley L. Hazen, J. Mark Brown, Michael A. Fischbach

Summary: By constructing variant communities of a complex defined microbial community, we found that removing specific strains occupying the bile acid 7a-dehydroxylation niche resulted in significant changes in the community composition and function. Strains that are functionally redundant within a niche can have differential impacts outside the niche, leading to unpredictable effects on unrelated community-level phenotypes. This study highlights the complexity of the gut microbiome and the importance of understanding individual strain dynamics in the context of the entire community.
Article Biotechnology & Applied Microbiology

gutSMASH predicts specialized primary metabolic pathways from the human gut microbiota

Victoria Pascal Andreu, Hannah E. E. Augustijn, Lianmin Chen, Alexandra Zhernakova, Jingyuan Fu, Michael A. A. Fischbach, Dylan Dodd, Marnix H. H. Medema

Summary: Profile hidden Markov models are used to identify taxon-specific primary metabolic pathways. The gut microbiota produce various small molecules that modulate host physiology. The gutSMASH algorithm is introduced to identify primary metabolic gene clusters in high-quality microbial genomes, revealing marked differences in pathway distribution among phyla and indicating a characteristic metabolic niche for each taxon. The study also highlights the crucial role of pathway-specific gene regulation and metabolite flux in microbiome-derived metabolites.

NATURE BIOTECHNOLOGY (2023)

Article Multidisciplinary Sciences

Engineered skin bacteria induce antitumor T cell responses against melanoma

Y. Erin Chen, Djenet Bousbaine, Alessandra Veinbachs, Katayoon Atabakhsh, Alex Dimas, Victor K. Yu, Aishan Zhao, Nora J. Enright, Kazuki Nagashima, Yasmine Belkaid, Michael A. Fischbach

Summary: Certain bacterial colonists induce a specific T cell response, even in the absence of infection. By engineering a skin bacterium to express tumor antigens, researchers were able to elicit tumor-specific T cells that infiltrate lesions and possess cytotoxic activity. This reveals the potential for commensal bacteria to be harnessed therapeutically for targeted immune responses.

SCIENCE (2023)

Article Cell Biology

Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus Cells

Amelie Kuhn, Jana Riegger, Graciosa Q. Teixeira, Markus Huber-Lang, John D. Lambris, Cornelia Neidlinger-Wilke, Rolf E. Brenner

Summary: Terminal complement complex deposition was found in human degenerated discs. The study investigated the mechanisms and effects of terminal complement activation in annulus fibrosus (AF) cells. Complement inhibitors effectively suppressed anaphylatoxin generation and TCC deposition induced by zymosan. Gene expression of ADAMTS4, MMP1, and COX2 was influenced by C3 and C5 blockade. Degenerated endplate tissue secreted soluble factors that enhanced direct C5 cleavage. These findings suggest the functional involvement of terminal complement activation in disc degeneration and the role of degenerated tissue in complement activation.
Article Cardiac & Cardiovascular Systems

Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality

Ina Nemet, Xinmin S. Li, Arash Haghikia, Lin Li, Jennifer Wilcox, Kymberleigh A. Romano, Jennifer A. Buffa, Marco Witkowski, Ilja Demuth, Maximilian Koenig, Elisabeth Steinhagen-Thiessen, Fredrik Backhed, Michael A. Fischbach, W. H. Wilson Tang, Ulf Landmesser, Stanley L. Hazen

Summary: Precision microbiome modulation has the potential to be a new treatment strategy for cardiovascular disease. This study used stable isotope dilution mass spectrometry to measure gut microbial metabolites and found that certain metabolites derived from aromatic amino acids are associated with adverse cardiovascular outcomes.

EUROPEAN HEART JOURNAL (2023)

Article Multidisciplinary Sciences

Mapping the T cell repertoire to a complex gut bacterial community

Kazuki Nagashima, Aishan Zhao, Katayoon Atabakhsh, Minwoo Bae, Jamie E. Blum, Allison Weakley, Sunit Jain, Xiandong Meng, Alice G. Cheng, Min Wang, Steven Higginbottom, Alex Dimas, Pallavi Murugkar, Elizabeth S. Sattely, James J. Moon, Emily P. Balskus, Michael A. Fischbach

Summary: Certain bacterial strains from the microbiome induce a potent T cell response, and many T cells in the gut repertoire recognize multiple bacterial strains. 13 T cell clones show a one-to-many TCR-to-strain relationship, recognizing 18 Firmicutes strains.

NATURE (2023)

Article Microbiology

Microbe-derived uremic solutes enhance thrombosis potential in the host

Ina Nemet, Masanori Funabashi, Xinmin S. Li, Mohammed Dwidar, Naseer Sangwan, Sarah M. Skye, Kymberleigh A. Romano, Tomas Cajka, Brittany D. Needham, Sarkis K. Mazmanian, Adeline M. Hajjar, Federico E. Rey, Oliver Fiehn, W. H. Wilson Tang, Michael A. Fischbach, Stanley L. Hazen

Summary: pCS and IS, gut microbiome-derived metabolites, are associated with cardiovascular disease risks and all-cause mortality. Microbial genes involved in the production of these metabolites can confer pro-thrombotic phenotype in vivo. Therapeutic targeting of gut microbial pathways may be a rational approach for CVD treatment.
Meeting Abstract Biochemistry & Molecular Biology

Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors

Christina Lamers, Martin Smiesko, Xiaoguang Xue, H. Van Son, Bea Wagner, G. Sfyroera, Nadja Berger, Piet Gros, John D. Lambris, Daniel Ricklin

MOLECULAR IMMUNOLOGY (2022)

Meeting Abstract Biochemistry & Molecular Biology

Platelet activation by commercial C4a preparations is mediated by trace impurities of thrombin

Richard Pouw, Joyce de Paula Souza, Jonas Kost, Said Rabbani, John Lambris, Daniel Ricklin

MOLECULAR IMMUNOLOGY (2022)

暂无数据